How has been the historical performance of Mankind Pharma?

Answer:The historical performance of Mankind Pharma shows a consistent growth trajectory in net sales and profitability over the past five years.

Breakdown:
Mankind Pharma's net sales have increased significantly from INR 6,214.43 crore in March 2021 to INR 12,207.44 crore in March 2025, reflecting a robust annual growth trend. Total operating income followed a similar pattern, rising from INR 6,214.43 crore in March 2021 to INR 12,207.44 crore in March 2025. The company's total expenditure, excluding depreciation, also grew from INR 4,566.33 crore in March 2021 to INR 9,189.51 crore in March 2025, indicating increased operational costs alongside revenue growth. Operating profit, excluding other income, improved from INR 1,648.10 crore in March 2021 to INR 3,017.93 crore in March 2025, showcasing enhanced operational efficiency. Profit before tax increased from INR 1,679.93 crore in March 2021 to INR 2,504.09 crore in March 2025, while profit after tax rose from INR 1,281.35 crore to INR 1,994.35 crore during the same period. The earnings per share (EPS) also saw a notable increase from INR 28.08 in March 2021 to INR 48.25 in March 2025, reflecting strong shareholder value creation. Overall, Mankind Pharma has demonstrated a solid financial performance with increasing revenues and profits over the years.